NEWS
31
Jul
2017
Novoheart expands facilities in Phase 3 of Hong Kong Science Park

Novoheart commences the expansion and renovation of its operations in Phase 3 of Hong Kong Science Park, into a 5,300 sq ft state-of-the-art facility with integrated office and laboratory space, fully equipped for stem cell culture, tissue engineering, hardware and software development, and drug screening applications of the MyHeartTM Platform. The brand new facilities are anticipated to open in December 2017.